Submit Deal

ATLAS VENTURE LP

HQ - Cambridge

Summary

Atlas Venture operates as a venture capital firm. The Company invests in life science and technology sectors. Atlas Venture serves clients in the United States.

Deals Overview

Total Deals32

Valued Deals32

Total Value£ 8.30 B

Avg. Deal Size£ 259 M

Market Context

Subsidiaries

CARBON BLACK

1 transaction

Senior Management

Cyrus Mozayeni
CEO
Ommer Chohan
CEO
Joanne Smith-Farrell
CEO

Sort

04 Oct 2017|United States|Consumer Lending

Target: EARNEST INC

Bidder: NAVIENT CORPORATION

21 Service Providers

2 Target | 2 Bidder | 17 Vendor

5 Dealmakers

1 Target | 2 Bidder | 34 Vendor

£ 116 M

Value

22 Aug 2019|United States|Software

Target: CARBON BLACK

Bidder: VMWARE INC

10 Service Providers

4 Target | 4 Bidder | 2 Vendor

37 Dealmakers

15 Target | 20 Bidder | 2 Vendor

£ 1.72 B

Value

20 Jul 2020|United States|Software

Target: DISPLAYLINK

Bidder: SYNAPTICS

9 Service Providers

2 Target | 2 Bidder | 5 Vendor

14 Dealmakers

2 Target | 5 Bidder | 7 Vendor

£ 241 M

Value

24 Jul 2020|China|Biotechnology

Target: HAIHE BIOPHARMA

Bidder: CHAOS INVESTMENT

10 Service Providers

2 Target | 8 Bidder

9 Dealmakers

1 Target | 8 Bidder

£ 134 M

Value

02 Sep 2020|United States|Gaming

Target: SKILLZ INC

Bidder: FLYING EAGLE ACQUISITION CORP

20 Service Providers

6 Target | 10 Bidder | 4 Vendor

70 Dealmakers

18 Target | 41 Bidder | 11 Vendor

£ 2.61 B

Value

15 Oct 2020|United States|Pharmaceuticals

Target: GEMINI THERAPEUTICS

Bidder: FS DEVELOPMENT CORP

13 Service Providers

5 Target | 5 Bidder | 3 Vendor

45 Dealmakers

17 Target | 20 Bidder | 8 Vendor

£ 166 M

Value

15 Oct 2020|United States|Biotechnology

Target: DISARM THERAPEUTICS

Bidder: ELI LILLY AND COMPANY

5 Service Providers

4 Target | 1 Bidder

7 Dealmakers

2 Target | 5 Bidder

£ 103 M

Value

29 Oct 2020|United States|Biotechnology

Target: VEDERE BIO INC

Bidder: NOVARTIS AG

5 Service Providers

2 Target | 1 Bidder | 2 Vendor

21 Dealmakers

15 Target | 5 Bidder | 2 Vendor

£ 215 M

Value

17 Dec 2020|United States|Biotechnology

Target: CADENT THERAPEUTICS

Bidder: NOVARTIS AG

5 Service Providers

2 Target | 1 Bidder | 2 Vendor

6 Dealmakers

3 Target | 1 Bidder | 2 Vendor

£ 576 M

Value

05 Jan 2021|United States|Biotechnology

Target: IKENA ONCOLOGY

Bidder: OMEGA FUNDS

15 Service Providers

3 Target | 12 Bidder

15 Dealmakers

3 Target | 12 Bidder

£ 88 M

Value

10 Feb 2021|United States|Biotechnology

Target: DAY ONE BIOPHARMACEUTICALS

Bidder: RA CAPITAL MANAGEMENT

11 Service Providers

2 Target | 9 Bidder

11 Dealmakers

2 Target | 9 Bidder

£ 94 M

Value

09 Jan 2020|United States|Biotechnology

Target: GENERATION BIO INC

Bidder: WELLINGTON MANAGEMENT

11 Service Providers

2 Target | 9 Bidder

12 Dealmakers

2 Target | 10 Bidder

£ 83 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy